A selective small-molecule nuclear factor-κB inhibitor from a high-throughput cell-based assay for “activator protein-1 hits”

Moon-Il Kang(Target (United States)), Nancy H. Colburn(Gene Therapy Laboratory), James B. McMahon(National Cancer Institute), Alyson R. Baker(National Cancer Institute), Curtis J. Henrich(Frederick National Laboratory for Cancer Research), Kirk R. Gustafson(Target (United States)), Matthew R. Young(NYU Langone Health), Heidi R. Bokesch(Frederick National Laboratory for Cancer Research)
Molecular Cancer Therapeutics
March 1, 2009
Cited by 19


Related Papers